Document:

Exhibit 4.16

 

OFFER TO SUBLEASE

 

		TO:	Home Trust Company

			(hereinafter referred to as the “Sublandlord”)

 

		FROM:	Ehave Inc.

			(hereinafter referred to as the “Subtenant”)

 

		RE:	Offer to Sublease the premises as leased (the “Head Lease”) to Home Trust Company (the
“Sublandlord”) by LPF Realty Office Inc. (the “Landlord”), located in the building known as 2020 Winston
Park Drive, Oakville, Ontario (the “Building”) on the 2nd floor of the Building (the “Premises”).

 

 

 

We, the Subtenant, hereby submit to the Sublandlord
this offer to sublease the Premises (the “Offer to Sublease”) under the following terms and conditions:

 

1.          SUBLEASE
PREMISES

The Premises shall be contain a gross rentable
area of approximately four thousand eight hundred and eight (4,808) square feet of Rentable Area on the 2nd floor of
the Building known as suite 201 and shown hatched on the floor plan attached as Schedule "A".

 

2.          TERM

The term of the sublease (the “Term”)
shall be for a period of nine (9) months commencing on February 1, 2017 (the “Commencement Date“) and expiring on October
30, 2017 (the “Expiration Date”).

 

3.          NET
RENT

The
“Net Rent” for the Premises shall be zero dollars ($0.00) per square foot of Rentable Area per annum throughout the
Term.

 

4.          ADDITIONAL
RENT

In addition to the Net Rent above, the Subtenant
shall also pay, as “Additional Rent”, its proportionate share of all operating costs, taxes and utilities relating
to the Premises as outlined in the Head Lease. Additional Rent for the calendar year 2016 is estimated by the Landlord to be fourteen
dollars and thirty five cents ($14.35) per square foot of Rentable Area per annum.

 

5.          DEPOSIT

Upon conditional acceptance of this Offer to
Sublease, the Subtenant shall promptly deliver a certified cheque in the amount equivalent to three (3) months Additional Rent
plus H.S.T. payable to the Listing Broker “in trust”, as a deposit (the “Deposit”) of which one (1) month
of the Deposit shall be applied against the first month’s Additional Rent (February, 2017), and the balance of the Deposit
shall be held by the Sublandlord as a Security Deposit for the Term.

 

6.          CONDITION
OF PREMISES

Subtenant accepts the Premises in its current
“as is” condition.

 

    	 	1

     

    

 

7.          FIXTURING
PERIOD

Provided the Landlord has provided its consent
to the Sublease and all required documentation has been executed by all parties, the Subtenant has submitted the Deposit to the
Sublandlord, obtained a certificate of insurance in accordance with the Head Lease, all conditions contained herein have been waived,
the Subtenant shall be granted access to the Premises, free of Net Rent and Additional Rent until the Commencement Date for its
intended use and to conduct its business (the “Fixturing Period”).

 

8.          FURNITURE

Provided the Landlord has provided its consent
to the Sublease and all required documentation has been executed by all parties, the Subtenant has submitted the Deposit to the
Sublandlord, obtained a certificate of insurance in accordance with the Head Lease, all conditions contained herein have been waived,
the Subtenant shall be granted the use of furniture (the “Furniture”) currently located in the Premises that are owned
by the Sublandlord. An itemized list of the Furniture, if available, shall be provided by the Sublandlord.

 

9.          REMOVAL
OF FIXTURES

Upon expiry of the Term, the Subtenant will
remove its trade fixtures and shall leave the Premises in vacant, broom swept condition, subject to the terms of the Lease.

 

10.         IDENTIFICATION

The Landlord, at the Subtenants expense, shall
provide and install base building signage on the building directory board and suite identification. All such signage shall comply
with the terms and conditions of the Head Lease and is subject to the prior written consent of the Landlord as required by the
Head Lease.

 

11.         SUBLEASE

Upon unconditional acceptance of this Sublease
by both parties and approval by the Landlord, this Offer to Sublease along with the attached Head Lease Agreement shall become
the Sublease Agreement. The Sublandlord and Subtenant agree to be bound by all the terms and conditions contained in the Head Lease,
subject to provisions contained in this Sublease and the Landlord’s Consent Document.

 

12.         LANDLORD
CONSENT

This Offer to Sublease is expressly conditional
for a period of five (5) business days following mutual execution by both parties upon the Sublandlord obtaining written consent
of this Offer to Sublease by the Landlord. If the Landlord does not provide written consent, then this Offer to Sublease shall
be null and void.

 

13.         NO
REPRESENTATION

It is agreed and understood that there are
no covenants, representations, agreements, warranties or conditions in any way relating to the subject matter contained in this
Offer to Sublease, whether express or implied, collateral or otherwise, except those set forth in this Offer to Sublease.

 

14.         WAIVER
TO AGENT 

The parties acknowledge that Cushman &
Wakefield Ltd., Brokerage has recommended that they obtain advice from their legal counsel prior to signing this document. The
parties further acknowledge that no information provided by Cushman & Wakefield Ltd., Brokerage is to be construed as expert
legal or tax advice.

 

    	 	2

     

    

 

15.         AGENCY
DISCLOSURE

The parties acknowledge and agree that Cushman
& Wakefield Ltd., Brokerage is representing and acting on behalf of the Sublandlord in this transaction.

 

16.         ELECTRONIC
ACCEPTANCE 

Acceptance of this Offer to Sublease may be
communicated by delivery of facsimile or electronic transmission of an accepted Offer to Sublease without limiting other methods
of communicating acceptance available to the parties.

 

17.         SUBLANDLORD’S
CONDITION

The Offer to Sublease is expressly conditional
for a period of five (5) business days from the date of mutual acceptance hereof (the “Sublandlord Conditional Period”)
upon the Sublandlord obtaining the approval of this Offer to Sublease and satisfactory review of the Subtenant’s covenant
and corporate structure by its President at its sole and absolute discretion. If the Sublandlord does not deliver notice in writing
to the Subtenant within the Conditional Period removing this condition, then this Offer to Sublease shall be null and void and
of no further effect. This condition has been inserted for the sole benefit of the Sublandlord and may be waived at any time by
written notice to the Subtenant.

 

18.         TIME
IS OF THE ESSENCE

Time is of the essence of this agreement and
each part of it.

 

19.         ACCEPTANCE
PERIOD

This Offer to Sublease is open for the Sublandlord’s
acceptance until 5:00 p.m., on the third (3rd) business day following execution by the Subtenant, after which time, if not accepted,
the Offer to Sublease shall be null and void and of no further force or effect.

 

The foregoing agreement is hereby agreed to
by the Subtenant.

 

Dated at the City of Toronto this 24 day of
January, 2017.

 

SUBTENANT:

Ehave Inc.

 

	Per: 	/s/ Prateek Dwivedi	 
	Name: 	Prateek Dwivedi	 
	Title: 	President & CEO	 

 

    	 	3

     

    

 

We hereby accept the foregoing Offer to Sublease.

 

Dated at the City of Toronto this 30 day of January, 2017.

 

SUBLANDLORD:

Home Trust Company

 

	Per:	/s/ Christer V. Ahlvik	 
	Name:	Christer V. Ahlvik	 
	Title:	EVP & Corporate Counsel	 

 

    	 	4

     

    

 

Schedule “A”

 

 

 

    	 	5Exhibit 4.17

 

Contract No. MHS-AIDA-EHA-20160922

 

API
Integration & DISTRIBUTION AGREEMENT

 

This Agreement is effective from the date of full execution
(the “Effective Date”) and is

 

between

 

MULTI-HEALTH SYSTEMS INC. (“MHS”),
a corporation duly organized and existing under the laws of the Province of Ontario, Canada, having offices at 3770 Victoria Park
Avenue, Toronto, Ontario, M2H 3M6, Canada.

 

and

ehave,
inc. (“Licensee”), a corporation duly organized and existing under the laws of the Province of Ontario,
Canada,

having offices at 250 University Avenue, Suite 200,
Toronto, Ontario, M5H 3E5, Canada.

 

MHS is in the business of publishing and
distributing assessment materials for professional use on a worldwide basis and providing training and certification for the appropriate
use of such materials.

 

Licensee is in the business of distributing
psychodiagnostic assessment materials in the Territory.

 

MHS wishes to grant to Licensee and Licensee
wishes to accept from MHS certain rights with respect to assessment materials published and/or distributed by MHS.

 

MHS and Licensee wish to ensure adherence
to the standards of the American Association of Test publishers or local equivalent by ensuring that assessment materials are used
anywhere in the world under professional auspices and controls similar to those required and exercised by MHS in the licensing
of such materials in the Territory.

 

For good and valuable consideration and
intending to be legally bound, the parties agree as follows:

 

		1.	DEFINITIONS 

 

The following definitions
will apply to this Agreement:

 

		1.1	“Confidential Information” includes the Test(s) and any and all of the confidential,
secret or proprietary information, materials and data related to Test(s) and individual Test Takers, including Research Materials,
in whatever form or medium, whether disclosed directly or indirectly, and includes but is not limited to, all copies and reproductions
of such information, in whole or in part, and all summaries, analyses, compilations, studies, notes and other records which contain,
reflect or are generated from such information.

 

		1.2	“Distribute” or “Distribution” means to promote, market and sublicense
to Qualified Users use of the MHS Tests within the Territory.

 

		1.3	“Initial Term” or “Term” has the meaning given to it in Section 9.1.

 

		1.4	“MHS Brand Identity Guidelines” means a set of rules regarding visual elements of an
MHS brand, including but not limited to, colour, design, logotype, name, and symbol.

 

		1.5	“MHS Inventory” means copies or use of the original English version of Tests and training
materials published by MHS as well as the original English versions of Scoring software published by MHS.

 

		1.6	“MHS Online Scoring System” means a web enabled
Scoring platform or any other MHS website or electronic medium for Scoring, sale, and sublicensing to Qualified Users use of the
MHS Inventory.

 

		1.7	“Qualified User” means the individuals described in Section 2.6.

 

		1.8	“Research Materials” means all information and data generated in developing any Translation,
or Adaptations or Standardizations of the Licensed Test, and includes but is not limited to information on Test Takers.

 

		1.9	“Scoring” means the administration of a Test to and the scoring, interpretation and
reporting on the results for, an individual Test Taker. Scoring of the Test can be effected by means of any MHS owned and/or approved
scoring methods and reporting platforms.

 

     

     

    

 

		1.10	“Territory” means North America.

 

		1.11	“Test” means collectively all materials published by MHS, in any form or medium, including
without limitation, Test items, normative data, technical and administrative manuals, clinical interview materials, rating criteria,
scoring templates, scoring algorithms, patterns and directions, score conversion tables, rating criteria, scoring software, printed
profile and interpretative reports, training manuals and numerical and graphic data relating to the Test. “Tests” refers
to all versions of Tests including the original version published by MHS and any translations, adaptations, and standardizations
thereof, including without limitation, any Translated Version, Adapted Version or Standardized Version developed under this Agreement.

 

		1.12	“Test Taker” means an individual who is assessed
using the Test.

 

		1.13	“Trademark” or “Trademarks” means the trademarks, service marks, logos
and trade names used from time to time by MHS in connection with its business and with Tests.

 

		2.	GRANT OF RIGHTS

 

		2.1	License Grant. In consideration of Licensee’s payments under Section 3, MHS hereby
grants to Licensee, subject to the terms of this Agreement:

 

(a)       the
non-exclusive, non-transferable and non-divisible license, without the right to sublicense such rights to any other party, to use
the Tests identified in Schedule III via MHS’ application programming interface (“API”) for inclusion and integration
into the Licensee’s mental health informatics platform (the “Licensee Platform”) and Distribution;

 

(b)       the
non-exclusive, non-transferable and non-divisible license, without the right to sublicense such rights to any other party, to create
and generate within the Licensee Platform output reports from the completed Tests after the Scoring of such Tests by MHS.

 

		2.2	Terms and Conditions of License. The license granted above is subject to the following terms
and conditions:

 

(a)       Licensee
shall implement a secure system on the Licensee Platform that is reasonably intended to restrict access of Test Takers to the Test
by way of requiring Test Takers to register certain personal information, such as their name, address (including zip/postal code)
and prior agreement to a “Consent Form” similar to that attached to this Agreement as Schedule “IV” or
as approved by MHS.

 

(b)       Licensee
shall inform all Test Takers and administrators who visit the Licensee Platform that they are prohibited from digitally copying,
saving, or temporarily storing the Test and may not use the Test for any purpose other than completing the administration.

 

(c)       Licensee
shall take reasonable security measures and encryption measures to protect the Test Taker information maintained by the Licensee
Platform.

 

(d)       Public
access to Licensee Platform shall not include the Test, except for brief descriptions of the Test and application methods, formulas
and diagnosis screens. The Licensee Platform shall not include any Confidential Information.

 

		2.3	Approved Format. The Licensee shall submit to MHS a proposed draft layout of the Test showing
the format in which the Licensee intends to use the Test items including the output report generated by the Licensee approved pursuant
to this Agreement. MHS shall notify Licensee in writing of its approval, or disapproval, within ten (10) business days of receipt
of submission. Licensee’s format of the Test items and output report shall mirror MHS’ online or software version of
the Test and shall bear the Copyright Notice as indicated in Schedule II. A submission shall hereafter be referred to as a “Format”
and a submission approved by MHS for use shall be referred to as an “Approved Format”.

 

		2.4	No Right to Adapt for Scoring. The rights granted in Section 2.1 above do not include the
right to generate norms or derive Scoring algorithms or to adapt Scoring instruments for the Scoring of Test.

 

		2.5	No Right to Modify. Licensee shall have no right to copy, modify, alter, translate, decompile,
reverse engineer or adapt any Test whatsoever. Licensee shall not use any Confidential Information in any way to compete with MHS
for any purpose including using same to create its own assessment tool or related materials.

 

		2.6	Third Parties. Licensee may not engage the services of any third party to perform any of
its obligations under this Agreement.

 

		2.7	Qualified Users. Tests may be sublicensed by Licensee hereunder only to professional individuals
qualified according to MHS’ Guidelines for Certification and Usage or the guidelines of the American Psychological Association
or equivalent local authority. Licensee shall not be permitted to provide feedback to Test Takers of the Test unless Licensee,
including employees, agents, or representatives are Qualified Users.

 

     

     

    

 

		2.8	No Distribution Outside Territory.  Licensee shall
not exercise any of the rights granted herein outside the Territory.

 

		2.9	No Public Domain Tools. “Public Domain Tools” refer to assessment tools or testing
or evaluation instruments which are available to the public free of charge. The Licensee shall refrain from including any Public
Domain Tools which MHS believes to materially infringe on any existing MHS intellectual property within any portion of the Licensee
Platform in which any MHS Tests reside.

 

		3.	LICENSEE PAYMENTS

 

		3.1	Consideration. In consideration for the rights granted to it under Section 2, Licensee shall
pay MHS the payments set out in Schedule I attached hereto and as it may be amended from time to time.

 

		4.	PROPRIETARY RIGHTS, COPYRIGHTS AND TRADEMARKS.

 

		4.1	Ownership.  Licensee acknowledges and agrees that all right, title and interest in and to
the Test are and will remain solely and exclusively vested in MHS. These rights are protected by Canadian intellectual property
right laws, international treaty provisions and other applicable national laws. During or after the Term of this Agreement, Licensee
shall not, in any manner, infringe such rights or contest or dispute the validity, enforceability or ownership thereof. The granting
of the licenses hereunder will not constitute a sale of the Test, in whole or in part, or the sale of any rights therein.

 

		4.2	Copyright Registration. Should MHS in its sole discretion determine that for the better
protection of the Test, Licensee shall file on behalf of MHS for registration or certification or notice of such right, title or
interest as may be required or are deemed desirable under the applicable laws in the Territory, MHS shall be responsible for the
costs and expenses in so doing.

 

		4.3	Copyright Notice. Licensee shall display the appropriate copyright notice in any pages or
screen displays that contain reproductions of the Test. This copyright notice is to appear as set out in Schedule II.

 

		4.4	Trademarks. Licensee agrees to abide by the MHS Trademark Guidelines in Schedule II and
to use the Trademarks solely in accordance with such Schedule II.

 

		4.5	Prohibition of Business Name. Licensee shall not use any Trademark as part of its legal
or business name or the name of any entity in which Licensee may have a direct or indirect interest.

 

		5.	CONFIDENTIAL INFORMATION

 

		5.1	Except as provided herein, Licensee agrees not to discloseany Confidential Information to any
third party, except to those of its employees or agents who have a need to know such information, and then only to the extent
necessary to exercise its rights under this Agreement.

 

		6.	MARKETING AND SALES RESPONSIBILITIES

 

		6.1	Marketing and Promotion. Licensee will work with MHS to adhere to the MHS Brand Identity
Guidelines for the Tests. The MHS Brand Identity Guidelines, if any, will be provided to Licensee upon execution of this Agreement.
MHS and Licensee agree to work together, from time to time as necessary, when creating any advertising, marketing or promotional
materials involving the Test. Licensee shall also exercise its best efforts, consistent with good business practice and the requirements
of this Agreement, to widely promote the use of Tests in the Territory. Licensee shall establish selling prices competitive within
the Territory. Under no circumstances shall the Licensee establish selling prices below those then in effect by MHS. MHS and Licensee
will collaborate as necessary on marketing and sales initiatives or public relations activities such as for co-branding purposes.
MHS and Licensee will work collaboratively on the identification and execution of any pilot customers prior to Licensee Platform
becoming operational.

 

		6.2	Licensee’s Scientific Advisory Board. A senior executive of MHS shall be appointed
a seat on the Licensee’s Scientific Advisory Board and acting as an active member.

 

		6.3	Annual Report. Licensee shall provide to MHS an annual report of sales of the prior twelve
(12) month period as well as a forecast of sales for the next twelve (12) month period annually, on the Effective Date, unless
otherwise agreed to by the parties.

 

		6.4	Price Increases. MHS agrees to notify Licensee in writing of price increases at least sixty
(60) days prior to the publication of any such price increases.

 

     

     

    

 

		6.5	Test Taker Data. The Licensee will provide aggregate Test Taker data and customer data to
MHS for MHS’ indefinite use surrounding the Test.

 

		6.6	Infringement. Licensee shall immediately report to MHS any infringement or unauthorized
use of or challenge to any of the intellectual property rights of MHS or its licensors of which the Licensee becomes aware. The
awareness of Licensee’s Employees shall be deemed the awareness of the Licensee. MHS shall have the sole discretion in determining
whether any action shall be taken on account of any infringement, unauthorized use, or challenge of the intellectual property rights.
MHS shall have no obligation or liability to Licensee with respect to any act or failure to act with respect to such infringement,
unauthorized use or challenge. MHS shall be entitled to take carriage of any legal action or proceeding commenced against Licensee
with respect to any intellectual property rights relating to this Agreement, provided that MHS complies with its obligations contained
in Section 7 of this Agreement.

 

		7.	INDEMNIFICATION.

 

		7.1	Indemnity by Licensee. Licensee will indemnify and hold MHS harmless from all claims, losses,
causes of action, actions, damages, expenses (including legal fees), costs, penalties and liabilities whatsoever arising out of
or in connection with any act or omission of Licensee under this Agreement or relating to it, including without limitation a claim
based on any representation or warranty made by Licensee with respect to the Test.

 

		7.2	Indemnity by MHS.  MHS will indemnify and hold Licensee harmless from all claims, losses
causes of action, actions, damages, expenses (including legal fees), costs, penalties and liabilities whatsoever arising out of
or in connection with any warranty made by MHS, except if such claim were based upon an unauthorized use of the Test.

 

		7.3	Defense. Either Licensee or MHS, as the case may be, (the “Indemnifying Party”),
will, at its own expense, defend any such action or claim and the other party will assist in the defense, provided that, so long
as the Indemnifying Party can demonstrate sufficient financial resources, the Indemnifying Party will control the defense and all
negotiations related to the settlement of any such action or claim, and further provided that any settlement intended to bind the
other party will not be final without the written consent of the other party, which will not be unreasonably withheld.

 

		8.	WARRANTIES & LIMITATION OF LIABILITY

 

		8.1	Warranty. MHS WARRANTS THAT IT HAS THE RIGHTS NECESSARY TO ENTER INTO THIS AGREEMENT. EXCEPT
AS PROVIDED IN THIS SECTION, MHS MAKES NO EXPRESS OR IMPLIED REPRESENTATIONS, WARRANTIES OR CONDITIONS OF ANY KIND IN RESPECT OF
THE TESTS, INCLUDING BUT NOT LIMITED TO, IMPLIED OR STATUTORY WARRANTIES OR CONDITIONS OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE.

 

		8.2	Licensee Representation and Warranty. The Licensee hereby represents and warrants to MHS
that it has all required capacity to enter into this Agreement and be bound by the obligations provided hereunder and that the
execution of this Agreement by the Licensee and the performance of its obligations hereunder will not constitute a violation or
breach of any obligation of any agreement between the Licensee and any third party or a violation by the Licensee of any legal
obligations.

 

		8.3	Limited Liability. MHS shall not be liable to Licensee under this Agreement for any special,
punitive or consequential damages or for any loss of profits or anticipated sales or savings or goodwill or on account of any expenditures,
investment, agreements or commitments made arising out of this Agreement or its termination.

 

		9.	TERM AND TERMINATION

 

		9.1	Term. The Initial Term of this Agreement shall be three (3) years commencing on the
Effective Date and unless earlier terminated as provided in this Section 9, shall expire three (3) years from the Effective Date.
If the Licensee wishes to renew this Agreement, the Licensee is required to contact MHS sixty (60) days prior to the expiry of
the Term and the parties will enter into discussions with respect thereto.

 

		9.2	Termination.  Notwithstanding the Term, either MHS or Licensee shall have the right to terminate
this Agreement forthwith upon delivery of written notice of termination to the other party, in the event that the other party fails
to comply with any term or condition of this Agreement and such non-compliance is not cured within the sixty (60) day period following
written notice thereof given by the non-defaulting party to the defaulting party.

 

		9.3	Rights upon Termination or Expiration.

 

		(a)	after expiration or termination of this Agreement, Licensee shall have no further right to exercise
the rights granted to it hereunder in any manner whatsoever;

 

		(b)	the Licensee shall immediately remove the Test from the Licensee Platform;

 

     

     

    

 

		(c)	all amounts due by Licensee including interest on outstanding invoices for any orders shipped by
MHS prior to expiration or termination shall become due and payable on the date of termination or expiration of this Agreement;
and

 

		(d)	within thirty (30) days of expiration or termination of this Agreement, each party shall return
to the other party all of the Confidential Information of the other party.

 

		10.	GENERAL PROVISIONS

 

		10.1	Assignment.  Except as expressly provided herein, Licensee shall have no right to assign
or transfer this Agreement or any of its rights or duties hereunder without the prior written consent of MHS.

 

		10.2	Currency.  Unless expressly stated otherwise, all monetary amounts referred to herein will
be in Canadian Dollars (CAD).

 

		10.3	Independent Contractors. The parties’ relationship during the Term of this Agreement
will be that of independent contractors. Under no circumstance shall this Agreement or any provision thereof be construed as creating
between the parties any relationship of employment, partnership, agency or joint ventures. Neither of the parties will have, and
will not represent that it has, any authority to bind the other party or to assume or create any obligation, express or implied,
on behalf of the other party. 

 

		10.4	Notice. Any notice or other communication required to be given hereunder by either party,
shall be in writing and shall be given by courier delivery, sent by registered mail, postage prepaid, or by facsimile transmission,
addressed to party for which it is intended at its address indicated in the recitals of parties to this Agreement to the attention
of, in the case of MHS, to the President & C.O.O., and in the case of Licensee, to the C.E.O. Either party may
change its address for purposes of receipt of any such communication by giving thirty (30) days notice of such change to the other
party in the manner prescribed above.

 

		10.5	Governing Law and Attornment. This Agreement shall be exclusively governed by, and construed
in accordance with the laws applicable in the Province of Ontario in Canada. Each party hereby attorns and submits to the jurisdiction
of the courts of the Province of Ontario in Canada.

 

		10.6	Returns. Materials returned to MHS shall be subject to the MHS Returns Policy, after which
any materials returned in salable condition shall be subject to a twenty (20%) re-stocking fee. MHS shall give the Licensee advance
notice of release dates for revised versions of MHS Inventory. At any time prior to such release date; the Licensee shall be entitled
to return the old versions of such MHS Inventory then in the Licensee's inventory.

 

		10.7	Injunctions. Licensee acknowledges and agrees that the covenants and conditions under this
Agreement are reasonable and necessary for the protection of MHS and its business, and that MHS may not have an adequate remedy
at law should Licensee breach this Agreement, and therefore MHS shall be entitled to injunctive relief in the event of any breach
of this Agreement by Licensee.

 

		10.8	Survival. Sections 4, 5, 7, 8, 9, and 10 shall survive termination of this Agreement.

 

		10.9	Force Majeure. MHS shall not be liable for any failure or delay in delivering MHS Inventory
to Licensee due to causes that are beyond the reasonable control of MHS.

 

		10.10	No Waiver.  No term or condition of this Agreement shall be deemed waived and no breach
consented to unless such waiver or consent shall be in writing and signed by the party claimed to have so waived or consented.
Any consent by any party to, or waiver of a breach by the other, whether express or implied, shall not constitute a consent to,
or waiver of, any different or subsequent breach.

 

		10.11	Severability. If any provision of this Agreement is determined to be invalid or unenforceable
by a court of competent jurisdiction or an arbitrator, that provision shall be deemed to be severed herefrom only to the extent
of the facts in dispute and the remaining provisions of this Agreement shall not be affected and shall remain valid and enforceable.

 

		10.12	Entire Agreement. This Agreement and the Schedules attached hereto constitutes the entire
Agreement between the parties pertaining to the subject matter hereof and supersedes and replaces any prior or contemporaneous
proposals, representations, discussions, drafts or proposed written contracts, letters of intent or understandings, whether written
or oral, express or implied, regarding such subject matter. No amendment, supplement or modification of this Agreement shall be
binding unless in writing and signed by an authorized signing officer for each of the parties respectively.

 

		10.13	Non-Disparagement. Licensee agrees, during the term of this Agreement and any time thereafter,
not to disparage, make false or misleading statements or otherwise engage in any action or make any statement that could harm the
business, operations, reputation or goodwill of MHS or its executives or personnel.

 

     

     

    

 

		10.14	Execution.  This Agreement may be executed in one or more counterparts, each of which shall
be deemed to be an original of the Agreement, and all of which, when taken together, shall be deemed to constitute one and the
same Agreement. Signatures to this Agreement transmitted by fax, by electronic mail in “portable document format” (“.pdf”),
or by any other electronic means intended to preserve the original graphic and pictorial appearance of the Agreement, shall have
the same effect as physical delivery of the paper document bearing the original signature.

 

		11.	SCHEDULES

 

		11.1	Schedules. The following are the schedules to this Agreement and are deemed to be a part
of it for all purposes:

 

Schedule I - Royalties & Other Payments

Schedule II - MHS Trademark & Copyright Guidelines

Schedule III - MHS Inventory Permitted for Distribution

Schedule IV - Consent Form

 

IN WITNESS WHEREOF the parties
have agreed that this Agreement be drawn in the English language and have executed this Agreement.

 

	
        MULTI-HEALTH SYSTEMS INC.

         

        /s/ Hazel Wheldon
	 	
        EHAVE, INC. 

         

        /s/ Prateek Dwivedi

	
        Hazel Wheldon, MA

        President & C.O.O.

         

        December 13, 2016
	 	
        Prateek Dwivedi

        C.E.O.

         

        December 13, 2016

	Date	 	Date

 

     

     

    

 

SCHEDULE I

 

Royalties
and Other Payments

 

All monetary references in this Schedule
are to Canadian Dollars (CAD).

 

		A.	For Materials Published by Licensee

 

		1.	Licensee shall pay MHS a fee equal to seventy percent (70%) of Net Sales of all copies of
the Test Published by Licensee as permitted under the Agreement (the “Fee”).

 

“Net Sales” is the
gross amount invoiced by Licensee for such Tests, less returns, transportation charges and sales or value added taxes. If such
Tests are bundled with other goods or services offered by Licensee, the Net Sales amount shall be computed on the basis of Licensee’s
then current regular catalogue prices for such Tests, notwithstanding any different or packaged pricing offered by Licensee as
part of the bundled goods or services.

 

		2.	Fees accrue when sales are invoiced. Reports of invoicing activity shall be produced quarterly
and sent to MHS by Licensee, within thirty (30) days of the end of each period, on April 30th, July 31st,
October 31st, and January 31st. Payments for the full Fee in each period shall accompany each report.

 

		3.	Tax Exemption Certificates – Licensee shall ensure any necessary Tax Exemption Certificates/Forms
from their country of origin are sent to MHS at the beginning of each calendar year in order to have the corresponding Canadian
Tax Authorities process these. Countries that have a Tax Exemption Agreement with Canada can avoid the double taxation via the
completion of the Tax Exemption Certificates/Forms. These forms must be sent to MHS every January of the calendar year royalties
are being paid.

 

		B.	In the event of any referrals by MHS to the Licensee of other publishers of psychological assessments,
MHS shall receive compensation in the form of percentages to be negotiated separately and/or equity for all finalized partnerships
resulting from such referral by MHS.

 

		C.	Catalogues and Sales Literature

 

Product catalogues
and sales literature are available to Licensee at cost plus shipping.

 

		D.	Payment Terms.

 

Licensee agrees to the following
payment terms:

 

		1.	All payments are due in thirty (30) days from date of invoice.

		2.	Shipping, handling, customs, and duty charges are to be borne by Licensee.

		3.	Items purchased shall not be accepted for refund or credit, except as provided in Section 10 of
the Agreement to which this Schedule is attached.

		4.	No orders will be filled if Licensee’s account is more than fifteen (15) days overdue.

 

Initialled by the Parties Hereto:

 

	 	
        MULTI-HEALTH SYSTEMS INC .

         

        /s/ Hazel Wheldon
	 	
        EHAVE, INC.

         

        /s/ Prateek Dwivedi

	 	
        Hazel Wheldon, MA

        President & C.O.O.
	 	
        Prateek Dwivedi

        C.E.O.

 

     

     

    

 

SCHEDULE II

 

MHS Trademark
and Copyright Guidelines

 

		A)	TRADEMARKS

 

Trademarks are words or symbols
that are used to identify a company’s products and services, and differentiate them from those offered by other organizations.
Trademarks are valuable assets.

 

In order to protect
Trademark assets, the following guidelines apply:

 

		·	Designation of Trademark Symbols: ®
identifies a Trademark that has been formally registered by the U.S. Patent and Trademark Office, Canadian Intellectual Property
Office, or local trademark office. TM designates an unregistered trademark associated with the product. 

 

		·	Use and display the appropriate trademark
symbol (either “TM” or “R” in a superscript following the Trademark) whenever the Trademark is used.

 

		·	Always use a Trademark as an adjective,
never as a noun. 

 

		·	Never change the form of a Trademark.

 

		·	Always display a Trademark with a trademark
notice such as “Benchmarks® is a registered Trademark of MHS”. The notice must be on the same page as the copyright
page of a document.

 

		·	Always display a Trademark with a trademark
notice.

 

		·	Trademark must be properly used with every
instance.

 

		·	All logo and Trademark formatting will
be provided by MHS.

 

		·	Licensee shall not use any Trademark as
part of its legal or business name or the name of any entity in which Licensee may have a direct or indirect interest.

 

		B)	COPYRIGHT STATEMENTS

 

For [Test]

Copyright ©[copyright date] Multi-Health
Systems Inc. (MHS). All rights reserved. Reproduced with permission from MHS.

 

Initialled by the Parties Hereto:

 

	 	
        MULTI-HEALTH SYSTEMS INC .

         

        /s/ Hazel Wheldon
	 	
        EHAVE, INC.

         

        /s/ Prateek Dwivedi

	 	
        Hazel Wheldon, MA

        President & C.O.O.
	 	
        Prateek Dwivedi

        C.E.O.

 

     

     

    

 

SCHEDULE III

 

Scope
of Services

 

Purpose 

 

The License is granted for the sole purposes
of inclusion and integration of the Tests via an MHS Application Programming Interface, within the Licensee’s mental health
informatics platform (the “Licensee Platform”).

 

MHS Tests

 

Application Programming Interface (“API”)
for select MHS Tests related to ADHD and Behavior.

The initial MHS Tests for integration will
be the Conners CBRS® and Conners 3®, as detailed in the Delivery of Services below.

 

Delivery of Services

 

Conners 3® API

Within thirty (30) days of execution of
the Agreement or such later date as is mutually agreed upon by the parties in writing, MHS will provide the Licensee with all relevant
documentation associated with the API delivery option for the Conners 3® as well as the necessary components in order to implement
this option accordingly.

 

Conners CBRS® API

On or before February 28th,
2017 or such later date as is mutually agreed upon by the parties in writing, MHS will provide the Licensee with all relevant documentation
associated with the API delivery option for the Conners CBRS® as well as the necessary components in order to implement this
option accordingly.

 

For any additional Tests, MHS and Licensee
will enter into mutual discussions for the scheduling and delivery of each potential Test API of which will be added to this Agreement
via a written Amendment duly signed by both parties.

 

Initialled by the Parties Hereto:

 

	 	
        MULTI-HEALTH SYSTEMS INC .

         

        /s/ Hazel Wheldon
	 	
        EHAVE, INC.

         

        /s/ Prateek Dwivedi

	 	
        Hazel Wheldon, MA

        President & C.O.O.
	 	
        Prateek Dwivedi

        C.E.O.

 

     

     

    

 

SCHEDULE IV

 

Consent
Form

 

TERMS AND CONDITIONS OF USE

 

PERMITTED ACCESS

 

You have been authorized to
enter this website for the purpose of completing a survey (the "Survey"). You understand that participation in
completing the Survey is entirely voluntary and if you wish to withdraw from completing the Survey, you may do so at any time without
explanation.

 

The information requested of
you on this website will be provided to Ehave, Inc. (“Ehave”) by Multi-Health Systems Inc. (“MHS”)
for the purposes of scoring, analyzing, and interpreting the Survey's results. You acknowledge that MHS has no control or influence
over Ehave’s use of the Survey's results or your information (including any personal information such as your age, responses
to items, scores, and other similar data) or the reports generated after you complete the Survey.

 

INFORMATION PRIVACY

 

We are committed to protecting
the privacy and security of the information transmitted on this website and we employ technology that secures the information and
prevents unauthorized access, use, or disclosure. We employ an advanced security system, Secure Socket Layers (SSL) encryption
technology to protect the transmission of information on this website.

 

You acknowledge that the Internet
is not an absolutely secure medium, and the privacy of your information, communications, and visits to this website cannot be guaranteed.

 

We reserve the right to store
de-personalized and aggregated data in our database indefinitely for research and statistical purposes by MHS, its affiliates,
subsidiaries, licensees, successors, assigns, suppliers, and advertisers.

 

YOUR RESPONSIBILITIES

 

You agree that you are responsible
for providing accurate and complete information when completing the Survey. You agree to use and access the website in a manner
that will not disrupt, corrupt, or otherwise damage the website. Accordingly, this website shall not be used in a manner that is
prohibited by law. Use of this website is subject to your compliance with all applicable laws and regulations in your location.

 

NO WARRANTY ON CONTENTS, INFORMATION, OR
MATERIALS

 

The information included in
this website does not constitute, and shall not be considered, the advice, recommendation, assessment, or endorsement of MHS. MHS
shall not be liable for any claims based on the use of the Survey. The Survey and other contents of this website are provided on
an "As Is" basis only. To the extent permitted by law, any statutory or implied warranty of merchantability or fitness
for a particular purpose are completely denied and disclaimed.

 

COPYRIGHT, LOGOS, AND TRADEMARKS

 

MHS is the copyright holder
of the Conners 3® and the Conners CBRS®. These rights are protected by Canadian intellectual property right laws, international
treaty provisions, and other applicable national laws. No portion of this assessment, including the information, text, images,
audio, or video, may be copied, modified, or used in any manner without prior written permission. Any name, logo, trademark, or
service mark contained and accessed by this website is owned or licensed by MHS or Ehave, as the case may, be and may not be used
in any manner without prior written permission. Unauthorized use of all or part of this assessment is strictly prohibited and may
result in the violation of trademark, privacy, copyright, and publicity rights.

 

     

     

    

 

GOVERNING LAW

 

This agreement shall be governed
by the laws of the Province of Ontario.

 

By clicking "I Accept"
below, you are indicating that you understand and agree to the Terms and Conditions of Use of this website.

 

By clicking “I Decline”
below, you are indicating that you do not wish to complete the Assessment.

 

		 ̈	I
have read, understood and accept the terms and conditions of use stated above.

 

		 ̈	I
decline to accept the terms and conditions of use stated above.

 

Initialled by the Parties Hereto:

 

	 	
        MULTI-HEALTH SYSTEMS INC .

         

        /s/ Hazel Wheldon
	 	
        EHAVE, INC.

         

        /s/ Prateek Dwivedi

	 	
        Hazel Wheldon, MA

        President & C.O.O.
	 	
        Prateek Dwivedi

        C.E.O.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}]]